Laboratorio Reig Jofre, S.A. (BME:RJF)

Spain flag Spain · Delayed Price · Currency is EUR
2.740
+0.050 (1.86%)
Apr 28, 2026, 5:18 PM CET
-6.16%
Market Cap 223.07M
Revenue (ttm) 336.68M
Net Income (ttm) 5.02M
Shares Out 81.41M
EPS (ttm) 0.06
PE Ratio 45.67
Forward PE 39.14
Dividend 0.05 (1.82%)
Ex-Dividend Date May 15, 2025
Volume 24,322
Average Volume 13,589
Open 2.710
Previous Close 2.690
Day's Range 2.710 - 2.740
52-Week Range 2.320 - 3.400
Beta 0.90
RSI 66.48
Earnings Date May 7, 2026

About Laboratorio Reig Jofre

Laboratorio Reig Jofre, S.A., a pharmaceutical company, researches, develops, manufactures, and markets pharmaceutical products, raw materials, biotechnological products, nutritional supplements, health products, medical devices, cosmetics, parapharmaceuticals, food, and other products. Its products also include pharmaceutical technologies products, such as antibiotics, and injectables and other products; specialty pharmacare products, which include skin, hair, nails, joint health and pain, and women’s health; and food supplements under the For... [Read more]

Sector Healthcare
Founded 1929
Employees 1,512
Stock Exchange Madrid Stock Exchange
Ticker Symbol RJF
Full Company Profile

Financial Performance

In 2025, Laboratorio Reig Jofre's revenue was 336.68 million, a decrease of -1.37% compared to the previous year's 341.37 million. Earnings were 5.02 million, a decrease of -51.64%.

Financial Statements

News

There is no news available yet.